Session Datesort descending
Morbidity, Mortality and Improvement Conference 03/26/2024 - 4:00pm to 5:00pm CDT
Rhabdoid Tumor Predisposition Syndrome with SMARCB1 Mutation and Novel Approaches in Treatment 04/09/2024 - 4:00pm to 5:00pm CDT
Treatment-Related Osteonecrosis in Hematology/Oncology Patients: An Overview of Risk Factors, Treatment and Management Strategies 04/16/2024 - 4:00pm to 5:00pm CDT
When Healers Cannot Heal: Ethical Considerations When Oncology Treatment is Declined 04/23/2024 - 4:00pm to 5:00pm CDT
Characteristics and Outcomes of Newly Diagnosed Aml Patients Who Deviated From the Standard Cog-Based Regimens and Received Alternative Therapy 04/30/2024 - 4:00pm to 5:00pm CDT
Insights on Managing Cancer Risks in Children with Hereditary Cancer Predisposition Syndromes (An Update) 05/07/2024 - 4:00pm to 5:00pm CDT
Deciphering Hyperinflammation: Differential Diagnosis and Initial Management Strategies for Hemophagocytic Lymphohistiocytosis (HLH) 05/14/2024 - 4:00pm to 5:00pm CDT
Morbidity, Mortality and Improvement Conference: Patient/Parent-Directed Refusal of Standard Pediatric Oncologic Care 05/21/2024 - 4:00pm to 5:00pm CDT
Thrombopoietin Receptor Agonists and Acute Myeloid Leukemia 05/28/2024 - 4:00pm to 5:00pm CDT
Retinoblastoma: Current Practice of Care and Failure Directions for Refractory Disease 06/04/2024 - 4:00pm to 5:00pm CDT

Pages